Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

61.49
-0.5374-0.87%
Volume:1K
Turnover:86.99K
Market Cap:288.98M
PE:20.11
High:62.20
Open:62.20
Low:61.49
Close:62.02
52wk High:64.10
52wk Low:39.76
Shares:4.70M
Float Shares:4.70M
Volume Ratio:0.33
T/O Rate:0.03%
Dividend:1.53
Dividend Rate:2.48%
EPS(TTM):3.06
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products

Stock News
·
2 hours ago

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

TIPRANKS
·
2 hours ago

Roivant Sciences Holds Annual Shareholder Meeting

Reuters
·
2 hours ago

Roivant Sciences Director Meghan FitzGerald Reports $203,159 Common Share Sale

Reuters
·
15 hours ago

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

Reuters
·
16 hours ago

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Reuters
·
Yesterday

Guardant Health on Track for Record High Close

Dow Jones
·
Yesterday

Stifel Nicolaus Initiates Roivant Sciences With Buy Rating, $51 Price Target

MT Newswires Live
·
Yesterday

Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

GlobeNewswire
·
Yesterday

Roivant Sciences Ltd : Stifel Initiates Coverage with Buy Rating; Target Price $51

THOMSON REUTERS
·
Yesterday

Roivant Sciences Price Target Announced at $51.00/Share by Stifel

Dow Jones
·
Yesterday

Roivant Sciences initiated with a Buy at Stifel

TIPRANKS
·
Yesterday

BrightSpring PharMerica President Scott A. Greenwell Sells 15,099 Shares for $874,380.09

Reuters
·
Yesterday

Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026

Deep News
·
Sep 16

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live
·
Sep 16

Revolution Medicines gets orphan designation for pancreatic cancer treatment

TIPRANKS
·
Sep 16

Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit

Stock News
·
Sep 15

Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits

Stock News
·
Sep 15

Roivant Sciences Ltd : Leerink Partners Raises Target Price to $52 from $42

THOMSON REUTERS
·
Sep 15

Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine

Stock News
·
Sep 15